FDA Inspection 1252556 — Missouri Baptist Medical Center Blood Bank
The FDA completed an inspection of Missouri Baptist Medical Center Blood Bank on Oct 22, 2024 in Saint Louis, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 22, 2024
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Saint Louis, MO (United States)